onecell diagnostics OneCell Diagnostics Raises $16M for AI Cancer Recurrence Detection OneCell Diagnostics secures $16 million to expand its AI-powered blood test that predicts cancer recurrence. The startup aims to bring its advanced genomics technology from India to the U.S. market.